IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q4 2018 Holdings

Filed 2019-02-13 | 10 holdings | $4.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$4.0M700,00095.6%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$71.0K2,968,6491.7%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$60.4K1,672,7141.4%
Alder BioPharmaceuticals, Inc.(ALDR1EUR)COM014339105$16.3K1,586,2200.4%
Insmed Incorporated(INSM)COM457669307$12.7K967,6360.3%
Epizyme, Inc.(EPZMEUR)COM29428V104$9.6K1,557,8640.2%
Acceleron Pharma Inc.(XLRN)COM00434H108$9.1K209,6020.2%
BioDelivery Sciences International, Inc.(BDSIUSD)COM09060J106$2.9K796,7330.1%
Twist Bioscience Corporation(TWST)COM90184D100$1.7K72,8490.0%
Natera, Inc.(NTRA)COM632307104$96469,0450.0%